Dose Effect of Limicol on (LDL)-Cholesterol Levels

Lescuyer Laboratory

Status: Completed

Conditions: Hypercholesterolaemia

Treatments: Other: Placebo; Dietary Supplement: Limicol

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT01354340

2011-A00145-36

Details and patient eligibility

About

The principal objective of this study is to investigate the dose-effect of the Limicol food supplement on LDL-cholesterol level in moderate hypercholesterolaemia subjects.

Enrollment: 45 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• About 18 to 65 years (inclusive).
• Subject has a stable weight for at least three months before the start of the study.
• Subject able and willing to comply with the protocol and agreeing to give their consent in writing.
• Subject affiliated with a social security scheme.
• Subject willing to be included in the national register of volunteers who lend themselves to biomedical research.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

45 participants in 3 patient groups, including a placebo group

Limicol simple dose

Experimental group

Treatment:

Dietary Supplement: Limicol

Dietary Supplement: Limicol

Limicol double doses

Experimental group

Treatment:

Dietary Supplement: Limicol

Dietary Supplement: Limicol

Placebo

Placebo Comparator group

Treatment:

Other: Placebo